We're #hiring a new Director of Marketing in Suwanee, Georgia. Apply today or share this post with your network.
Femasys Inc.
Medical Equipment Manufacturing
Suwanee, Georgia 6,856 followers
Femasys is a biomedical company focused on transforming women’s healthcare worldwide.
About us
Femasys is a biomedical company focused on transforming women’s healthcare worldwide by developing novel solutions and next-generation advancements providing significant clinical impact to address severely underserved areas. With an initial focus in the area of reproductive health, its two lead product candidates offer solutions to improve patient care and health economics: FemBloc®, a first and only non-surgical product for permanent birth control and FemaSeed™, a first and only directed sperm delivery product for infertility treatment. Femasys’ FemVue® product for fallopian tube assessment by ultrasound is currently marketed in the United States as its main commercial priority. Femasys has also developed a novel technology platform for tissue sampling intended to be marketed alongside our other women-specific medical products in the physician’s office setting.
- Website
-
http://www.femasys.com
External link for Femasys Inc.
- Industry
- Medical Equipment Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Suwanee, Georgia
- Type
- Public Company
Locations
-
Primary
3950 Johns Creek Ct
Suite 100
Suwanee, Georgia 30024, US
Employees at Femasys Inc.
Updates
-
We're #hiring a new Product Development Engineer in Suwanee, Georgia. Apply today or share this post with your network.
-
We're #hiring a new Office Administrator in Suwanee, Georgia. Apply today or share this post with your network.
-
Be sure to check out part two of our interview with @Don Tracy from @Pharmaceutical Executive, where CEO Kathy Lee-Sepsick explains the results of our latest FemaSeed® trial and our FemBloc® permanent birth control! https://lnkd.in/ee4y2WjF #Femasys #Femaseed #FemBloc #Infertility
-
Watch part one of our interview with Don Tracy from @Pharmaceutical Executive, where we explain how our Femaseed technology supports women facing infertility challenges. https://lnkd.in/eW7PnrKp #Femasys #Femaseed #infertility
Femasys Founder Discusses Femaseed Technology Designed to Support Infertility
pharmexec.com
-
Femasys Receives CE Mark Approval for Four of its Women’s Health Products Clearing the Path for the Company to Begin Commercialization Efforts in Europe. https://lnkd.in/eWANMtbT
Femasys Receives CE Mark Approval for Four of its Women’s Health Products Clearing the Path for the Company to Begin Commercialization Efforts in Europe
globenewswire.com
-
We are proud to have Kathy Lee-Sepsick as our visionary CEO driving Femasys forward! On "The Founder CEO," Kathy discusses her journey to revolutionize women's healthcare with safer, more effective birth control solutions inspired by her own experiences. Watch the full Entrepreneur Media interview here: https://lnkd.in/eugZyk9F #Femasys #WomensHealth #Leadership
How This CEO Is Fighting to Innovate Women's Healthcare | Entrepreneur
entrepreneur.com
-
The Supreme Court's decision not to reject mifepristone marks a significant step for reproductive healthcare access. At Femasys, we applaud this decision as it aligns with our mission to innovate and empower women with safe and effective healthcare solutions. Read the full @FiercePharma article for more details: https://lnkd.in/e77wQPfB #Femasys #ReproductiveHealth #SupremeCourtDecision
AstraZeneca backs up Calquence's potential in mantle cell lymphoma with detailed data
fiercepharma.com
-
"Over 100 years of stagnant innovation could lead to a $20 billion market expansion opportunity for FemBloc in the U.S. alone as we look to address the needs of the over 13 million women who no longer intend to have children.” CEO Kathy Lee-Sepsick shares market insights with @Benzinga and Femasys' vision for transforming women's health with commercially available products like FemaSeed, FemVue, FemCath, and FemCerv.